These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7059293)

  • 1. Absence of Carp's agent in sera of patients with multiple sclerosis in Japan.
    Homma M; Yokota N; Tashiro M; Arai S; Ohara Y; Takase S; Itahara K
    Arch Neurol; 1982 Feb; 39(2):117-9. PubMed ID: 7059293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of MS associated factors for test procedures in multiple sclerosis: 1. Carp's MS associated agent in the serum].
    Meyer-Rienecker HJ; Olischer RM; Lehmitz R
    Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):708-13. PubMed ID: 6669653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis-associated agent: transmission to animals and some properties of the agent.
    Koldovsky U; Koldovsky P; Henle G; Henle W; Ackermann R; Haase G
    Infect Immun; 1975 Dec; 12(6):1355-66. PubMed ID: 1205617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multiple sclerosis materials on polymorphonuclear neutrophils of mice.
    Mackay IR; Godycki L; Tourtelotte WW
    Acta Neurol Scand; 1980 Jan; 61(1):1-8. PubMed ID: 7395453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients.
    Carp RI; Licursi PC; Merz PA; Merz GS
    J Exp Med; 1972 Sep; 136(3):618-29. PubMed ID: 4626194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis-associated agent. Failure of MS brain and serum to depress the polymorph count in normal mice and mice inoculated with cells containing C/type particles.
    Cobill JM; Hughes D; Keith AB; Cameron KR; Mason J; Caspary EA
    J Neurol Sci; 1979 Mar; 41(1):11-6. PubMed ID: 220388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte functions and multiple sclerosis.
    Podikoglou DG; Lianou PE; Tsakanikas CD; Papavassiliou JT
    Neurology; 1994 Jan; 44(1):129-32. PubMed ID: 8290047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis associated agent (MSAA): failure to confirm an association with multiple sclerosis.
    Madden DL; Krezlewicz A; Gravell M; Sever JL; Tourtellotte WW
    Neurology; 1978 Mar; 28(3):295-9. PubMed ID: 564484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-sclerosis-associated agent.
    Madden DL; Krezlewicz AG; Gravell M; Sever JL; Tourtellotte WW
    Lancet; 1977 Nov; 2(8045):976. PubMed ID: 72308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters].
    Mazor R; Shurtz-Swirski R; Sela S; Shapiro G; Kristal B
    Harefuah; 2006 Dec; 145(12):900-3, 941. PubMed ID: 17220029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-sclerosis-associated agent.
    Lancet; 1977 Oct; 2(8042):814-5. PubMed ID: 71613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polymorphonuclear rosettes in the peripheral blood of multiple sclerosis patients].
    Matveeva TV; Kamzeev VD; Shaĭdullina FS; Riazantseva IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):133-6. PubMed ID: 106611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte lysosome activities and lymphocyte transformation in multiple sclerosis and some other central nervous system chronic diseases.
    Tchórzewski H; Czernicki J; Maciejek Z
    Eur Neurol; 1976; 14(5):386-96. PubMed ID: 949988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical cytoskeleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients.
    Itakura Sumi Y; Ogura H; Tanaka H; Koh T; Fujita K; Fujimi S; Nakamori Y; Shimazu T; Sugimoto H
    J Trauma; 2003 Dec; 55(6):1125-32. PubMed ID: 14676659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective adherence of polymorphonuclear leukocytes to nylon induced by thalassemic serum.
    Bassaris HP; Lianou PE; Skoutelis AT; Papavassiliou JT; Phair JP
    J Infect Dis; 1982 Jul; 146(1):52-5. PubMed ID: 7086204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients.
    Kristal B; Shurtz-Swirski R; Shasha SM; Manaster J; Shapiro G; Furmanov M; Hassan K; Weissman I; Sela S
    Nephron; 1999; 81(4):406-13. PubMed ID: 10095176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymorphonuclear leukocyte contributes to the development of hypertension in the Sabra rat.
    Mazor R; Kristal B; Cohen-Mazor M; Yagil C; Yagil Y; Sela S
    J Hypertens; 2007 Nov; 25(11):2249-56. PubMed ID: 17921819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical changes in carp's organism produced by the administration of antigens].
    EPSHTEIN IaA; AVERTIKIAN BG; LAVROVSKAIA NF; ROGOZHNIKOVA VM; ARTEMOVA AG
    Biokhimiia; 1960; 25():427-35. PubMed ID: 13849724
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukapheresis in multiple sclerosis.
    Sibley WA; Heustis DW; Griffith MM
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):521-5. PubMed ID: 616552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.
    Mazor R; Shurtz-Swirski R; Farah R; Kristal B; Shapiro G; Dorlechter F; Cohen-Mazor M; Meilin E; Tamara S; Sela S
    Atherosclerosis; 2008 Apr; 197(2):937-43. PubMed ID: 17869258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.